Grade 2 Meningioma

Oncology·MeSH: Meningioma

Prevalence

5.0 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Grade 2 Meningioma?

There are 1 clinical trial targeting Grade 2 Meningioma tracked by BioSniper.

What is the prevalence of Grade 2 Meningioma?

The estimated prevalence of Grade 2 Meningioma is approximately 5.0 per 100,000 population.

Deep-dive into Grade 2 Meningioma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Grade 2 Meningioma — Drugs in Development & Clinical Trials | BioSniper